Surgepays Inc (NASDAQ: SURG) closed the day trading at $4.55 up 10.98% from the previous closing price of $4.10. In other words, the price has increased by $+0.4500 from its previous closing price. On the day, 892975 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of SURG, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’23 when Cox Kevin Brian bought 5,200 shares for $4.72 per share. The transaction valued at 24,544 led to the insider holds 4,507,894 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 87.93M and an Enterprise Value of 78.75M. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.64 while its Price-to-Book (P/B) ratio in mrq is 2.32. Its current Enterprise Value per Revenue stands at 0.57 whereas that against EBITDA is 3.92.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $3.65. The 50-Day Moving Average of the stock is 6.8383, while the 200-Day Moving Average is calculated to be 5.9089.
Shares Statistics:
Over the past 3-months, SURG traded about 859.72K shares per day on average, while over the past 10 days, SURG traded about 1.3M shares per day. A total of 14.40M shares are outstanding, with a floating share count of 12.95M. Insiders hold about 32.88% of the company’s shares, while institutions hold 7.05% stake in the company. Shares short for SURG as of Feb 29, 2024 were 1.86M with a Short Ratio of 2.17, compared to 1.92M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.98% and a Short% of Float of 16.48%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of $0.29 for the current quarter, with a high estimate of $0.29 and a low estimate of $0.29, while EPS last year was $0.31. The consensus estimate for the next quarter is $0.24, with high estimates of $0.24 and low estimates of $0.24.
Analysts are recommending an EPS of between $1 and $1 for the fiscal current year, implying an average EPS of $1. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
1 analysts predict $32.32M in revenue for the current quarter. It ranges from a high estimate of $32.32M to a low estimate of $32.32M. As of the current estimate, Surgepays Inc’s year-ago sales were $36.5M, an estimated decrease of -11.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $32.32M, a decrease of -17.20% less than the figure of -$11.50% in the same quarter last year. There is a high estimate of $32.32M for the next quarter, whereas the lowest estimate is $32.32M.
A total of 1 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $129.28M, while the lowest revenue estimate was $129.28M, resulting in an average revenue estimate of $129.28M. In the same quarter a year ago, actual revenue was $137.14M, down -5.70% from the average estimate.
